A lawsuit alleging that 20 generic drug makers colluded to fix prices reveals how existing market-based, competitive mechanisms fail to protect consumers.

  • SIGN UP FOR OUR EMAIL NEWSLETTER
    Sign up for the weekly Knowledge@Wharton e-mail newsletter, offering business leaders cutting-edge research and ideas from Wharton faculty and other experts.